Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections

被引：19

作者：

Mitton-Fry, Mark J. ^{[1
]}

Arcari, Joel T. ^{[1
]}

Brown, Matthew F. ^{[1
]}

Casavant, Jeffrey M. ^{[1
]}

Finegan, Steven M. ^{[3
]}

Flanagan, Mark E. ^{[1
]}

Gao, Hongying ^{[4
]}

George, David M. ^{[3
]}

Gerstenberger, Brian S. ^{[1
]}

Han, Seungil ^{[5
]}

Hardink, Joel R. ^{[4
]}

Harris, Thomas M. ^{[1
]}

Thuy Hoang ^{[1
]}

Huband, Michael D. ^{[3
]}

Irvine, Rebecca ^{[3
]}

Lall, Manjinder S. ^{[1
]}

Lemmon, M. Megan ^{[3
]}

Li, Chao ^{[1
]}

Lin, Jian ^{[4
]}

McCurdy, Sandra P. ^{[3
]}

Mueller, John P. ^{[3
]}

Mullins, Lisa ^{[3
]}

Niosi, Mark ^{[4
]}

Noe, Mark C. ^{[1
]}

Pattavina, David ^{[6
]}

Penzien, Joseph ^{[3
]}

Plummer, Mark S. ^{[1
]}

Risley, Hud ^{[1
]}

Schuff, Brandon P. ^{[1
]}

Shanmugasundaram, Veerabahu ^{[2
]}

Starr, Jeremy T. ^{[1
]}

Sun, Jianmin ^{[1
]}

Winton, Jennifer ^{[4
]}

Young, Jennifer A. ^{[1
]}

机构：

[1] Pfizer Worldwide Res & Dev, Med Chem, Groton, CT 06340 USA

[2] Pfizer Worldwide Res & Dev, Computat Chem, Groton, CT 06340 USA

[3] Pfizer Worldwide Res & Dev, Antibacterials Res Unit, Groton, CT 06340 USA

[4] Pfizer Worldwide Res & Dev, Pharmacokinet Dynam & Metab, Groton, CT 06340 USA

[5] Pfizer Worldwide Res & Dev, Struct Biol, Groton, CT 06340 USA

[6] Pfizer Worldwide Res & Dev, Analyt R&D, Groton, CT 06340 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 18期

关键词：

Monobactam; Gram-negative; Pseudomonas aeruginosa; Klebsiella pneumoniae; Escherichia coli; Siderophore; MC-1; BETA-LACTAM ANTIBIOTICS; ANTIBACTERIAL ACTIVITY; CATECHOL MOIETY; CEPHALOSPORINS; MONOCARBAMS; DERIVATIVES; BAL30072;

D O I：

10.1016/j.bmcl.2012.07.005

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：5989 / 5994

页数：6

共 50 条

[41] Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens
Ruiz Ramos, Jesus
Salavert Lleti, Miguel
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019, 32 : 45 - 54
[42] Bifurcation kinetics of drug uptake by Gram-negative bacteria
Westfall, David A.
Krishnamoorthy, Ganesh
Wolloscheck, David
Sarkar, Rupa
Zgurskaya, Helen I.
Rybenkov, Valentin V.
PLOS ONE, 2017, 12 (09):
[43] Fosfomycin for the Treatment of Resistant Gram-Negative Bacterial Infections Insights from the Society of Infectious Diseases Pharmacists
Reffert, Julia L.
Smith, Winter J.
PHARMACOTHERAPY, 2014, 34 (08): : 845 - 857
[44] Seasonality in Gram-negative and healthcare-associated infections
Richet, H.
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (10) : 934 - 940
[45] Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections
Tsilika, Maria
Ntziora, Fotinie
Giannitsioti, Efthymia
PATHOGENS, 2025, 14 (02):
[46] Antimicrobial-resistant Gram-negative infections in neonates: burden of disease and challenges in treatment
Folgori, Laura
Bielicki, Julia
Heath, Paul T.
Sharland, Mike
CURRENT OPINION IN INFECTIOUS DISEASES, 2017, 30 (03) : 281 - 288
[47] Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
Dobias, J.
Denervaud-Tendon, V.
Poirel, L.
Nordmann, P.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (12) : 2319 - 2327
[48] Antibiotic Conjugates with an Artificial MECAM-Based Siderophore Are Potent Agents against Gram-Positive and Gram-Negative Bacterial Pathogens
Pinkert, Lukas
Lai, Yi-Hui
Peukert, Carsten
Hotop, Sven-Kevin
Karge, Bianka
Schulze, Lara Marie
Grunenberg, Jorg
Broenstrup, Mark
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (20) : 15440 - 15460
[49] Novel Antimicrobial Agents for Gram-Negative Pathogens
Karvouniaris, Marios
Almyroudi, Maria Panagiota
Abdul-Aziz, Mohd Hafiz
Blot, Stijn
Paramythiotou, Elisabeth
Tsigou, Evdoxia
Koulenti, Despoina
ANTIBIOTICS-BASEL, 2023, 12 (04):
[50] CURRENT CONCEPTS Hospital-Acquired Infections Due to Gram-Negative Bacteria
Peleg, Anton Y.
Hooper, David C.
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (19) : 1804 - 1813

← 1 2 3 4 5 →